Search

everythinglearnresearchcommunity

for

Search:↓

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Cancer development is like natural selection, involving mutated cells and environmental factors.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Early balding at 40 increases prostate cancer risk.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Different types of skin cells play specific roles in development, healing, and cancer.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

New treatments for diabetes, central nervous system repair, and cartilage injury were found, and a way to create functional hair follicles from stem cells was developed.

Women with alopecia may have a higher chance of getting thyroid cancer.

PCOS may increase the risk of certain cancers.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

PLD is an effective and safer alternative for treating breast cancer.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride does not prevent bladder cancer.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.